Myriad Genetics (MYGN) Divestments (2020 - 2021)
Myriad Genetics (MYGN) reported Divestments of $379.1 million for Q3 2021, up 1679.81% year-over-year from $21.3 million in Q3 2020, and up 1679.81% quarter-over-quarter from $21.3 million in Q3 2020.
Myriad Genetics (MYGN) Divestments (2020 - 2021) Analysis & Trends
Myriad Genetics (MYGN) has 2 years of Divestments data on file, last reported at $379.1 million in Q3 2021.
- Divestments for Q3 2021 came in at $379.1 million, up 1679.81% year-over-year; the trailing twelve-month figure through Dec 2024 was $379.1 million (changed 0.0% YoY), and the FY2024 annual result was $8.8 million, changed N/A from the prior year.
- Divestments rose to $379.1 million in Q3 2021 per MYGN's latest filing, from $21.3 million in the prior quarter.
- Over five years, Divestments peaked at $379.1 million in Q3 2021 and troughed at -$21.3 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | - |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | - |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | - |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | - |
| 10 | Myriad Genetics | 411.34 Mn | 286.94 Mn | 137.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 379.10 Mn |
| Sep 30, 2020 | 21.30 Mn |
| Jun 30, 2020 | -21.30 Mn |
| Mar 31, 2020 | 21.30 Mn |